Attention Long-Term Aldeyra Therapeutics, Inc. (ALDX) Investors: Grabar Law Office Is Investigating Claims on Your Behalf

4d ago, source:

Grabar Law Office is investigating claims on behalf of Aldeyra shareholders. The investigation concerns whether certain officers of Aldeyra have breached their fiduciary duties owed to the company.

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Is About To Turn The Corner

17d ago, source: Yahoo Finance

Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Aldeyra Therapeutics, Inc., a ...

Aldeyra (ALDX) Stock Rallies 43% in One Week: Here's Why

13d ago, source: Zacks.com on MSN

Aldeyra Therapeutics’ALDX clinical-stage immunology pipeline comprises two candidates, reproxalap and ADX-629, which are undergoing late-stage and mid-stage development, respectively. The company’s ...

Aldeyra Therapeutics Inc 137

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Aldeyra Therapeutics Stock (NASDAQ:ALDX), Analyst Ratings, Price Targets, Predictions

17d ago, source: Benzinga.com

Aldeyra Therapeutics Inc has a consensus price target of $9.67, established from looking at the 19 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, HC Wainwright ...

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

22d ago, source: Stockhouse

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today ...

Grabar Law Office Investigates Claims on Behalf of Shareholders of Aldeyra Therapeutics, Inc. (ALDX)

1mon ago, source: Business Insider

Philadelphia, Pennsylvania--(Newsfile Corp. - March 20, 2024) - Attention long-term shareholders of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX): A recently filed securities fraud class action ...

Esperion Therapeutics, Inc. (ESPR)

1d ago, source: Yahoo Finance

Heron Therapeutics, Lyra Therapeutics and Aldeyra Therapeutics are part of the ... Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript February 27, 2024 Esperion ...